The McMaster Nuclear Reactor, the first university-based research reactor in the British Commonwealth, began operations in 1959. It now serves a core group of researchers exploring the smallest structures of matter, developing new probes for medical diagnostics and studying radiation safety. It also is one of the world’s largest suppliers of the medical radioisotope iodine-125 which is used for the treatment of prostate cancer.